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Abstract 
Background: Some marine bacteria, such as Moritella marina, produce the nutraceutical docosahexaenoic acid 
(DHA) thanks to a specific enzymatic complex called Pfa synthase. Escherichia coli heterologously expressing the pfa 
gene cluster from M. marina also produces DHA. The aim of this study was to find genetic or metabolic conditions to 
increase DHA production in E. coli.
Results: First, we analysed the effect of the antibiotic cerulenin, showing that DHA production increased twofold. 
Then, we tested a series of single gene knockout mutations affecting fatty acid biosynthesis, in order to optimize the 
synthesis of DHA. The most effective mutant, fabH, showed a threefold increase compared to wild type strain. The 
combination of cerulenin inhibition and fabH deletion rendered a 6.5‑fold improvement compared to control strain. 
Both strategies seem to have the same mechanism of action, in which fatty acid synthesis via the canonical pathway 
(fab pathway) is affected in its first catalytic step, which allows the substrates to be used by the heterologous pathway 
to synthesize DHA.
Conclusions: DHA‑producing E. coli strain that carries a fabH gene deletion boosts DHA production by tuning down 
the competing canonical biosynthesis pathway. Our approach can be used for optimization of DHA production in 
different organisms.
Keywords: Fatty acid synthesis, Polyunsaturated fatty acid, Docosahexaenoic acid, Cerulenin, FabH
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Consumption of long-chain polyunsaturated fatty acids 
of the omega-3 series (LC-PUFA3) has been associated 
to benefits for human health [1]. LC-PUFA3 are found 
in membrane phospholipids and are especially abundant 
in neuron and retina. LC-PUFA3 play a major impact 
during fetal development, as well as in Alzheimer’s dis-
ease progression [1]. Furthermore, they reduce chronic 
inflammation, which is the cause of many cardiovascular 
diseases [2]. Since only limited amounts of LC-PUFA3 
are synthesized in humans from α-linolenic acid (the 
main LC-omega-3 FA in vegetables), the Food and Agri-
culture Organization [3] recommends a minimum intake 
of 250  mg LC-PUFA3 per day, while pregnant women 
intake must be 300 mg/day, of which 200 mg should be 
docosahexaenoic acid (DHA). However, the recom-
mended daily intake is not reached in many countries, 
where consumption of fish and seafood is insufficient.
Currently, the main source of supplemented LC-PUFA3 
is fish oil. Problems arise in the industrial production of 
LC-PUFA3, such as elevated purification costs, low sta-
bility of the molecules, undesirable odors, flavors and 
tastes, or the presence of a wide range of contaminants, 
including heavy metals. Furthermore, concerns about 
the sustainability of fisheries have increased the efforts 
towards alternative production sources [4, 5].
Besides fish, animals, plants, fungi and microalgae syn-
thesize LC-PUFA3 from α-linolenic acid by consecutive 
elongation and desaturation reactions. However, thraus-
tochytrids and a group of deep-sea bacteria are able to 
produce de novo LC-PUFA3 by a multi-enzymatic pro-
tein complex named polyunsaturated fatty acid synthase 
(Pfa) [6]. The mechanism has not been characterized in 
detail, but is thought to be similar to Type II polyketide 
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synthases (PKS) and de novo fatty acid synthases (FAS). 
LC-PUFA3 synthesis begins by the condensation of a 
malonyl group bound to an acyl-carrier protein (ACP) 
with an acetyl-CoA. This reaction is carried out by a 
β-ketoacyl-ACP synthase domain (KS). Later, there are 
several cycles of reduction, dehydration, reduction and 
condensation, to produce a 20-carbon long chain with 
five double bonds (C20:5, eicosapentaenoic acid, EPA) 
or a 22-carbon long chain with six double bonds (C22:6, 
DHA) [7, 8]. Orikasa et  al. [7] cloned the five essen-
tial genes for DHA production from marine bacteria 
Moritella marina into an E. coli expression vector. The 
resulting plasmid, named pDHA4 (Table 1), contains M. 
marina pfaABCD genes under control of native promot-
ers, while pfaE is controlled by a T7 promoter. E. coli 
strain DH5α containing pDHA4 produced 3.7% DHA of 
total FAs after 96 h at 15 °C [7].
DHA production can be improved by treatment with 
sub-lethal concentrations of cerulenin. This antibiotic 
increased DHA production in M. marina [9], Colwellia 
psycherythraea [10], Thraustrochytrium sp. [11], and 
even in E. coli expressing the heterologous Pfa system [7, 
12]. Pfa synthase is similar to Fatty Acid Synthase (FAS), 
responsible for short and medium chain fatty acid bio-
synthesis and uses the same substrates, malonyl-CoA and 
acetyl-CoA. In E. coli, de novo FAS-based FA synthesis 
uses three KS enzymes named FabB, FabF and FabH, 
which initiate FA elongation cycle. Although the three 
KS enzymes are structurally similar and participate in a 
similar reaction, the antibiotic cerulenin inhibits FabB 
and FabF, but not FabH [13, 14]. Thus, inhibition of FabB 
and FabF by cerulenin decreases the amount of substrate 
consumed by FAS, increasing by 50-fold the intracellular 
level of malonyl-CoA available for heterologous synthetic 
pathways [15].
In this article we tested single gene in-frame knock-
outs in E. coli to find genetic modifications which 
improve the DHA production by Pfa heterologous sys-
tem from M. marina. In particular, we found that fabH 
deletion produced a threefold improvement compared to 
the wild type reference strain. This modification could be 
used in oleaginous DHA-producing microbial species to 
enhance the production of this added-value fatty acid.
Results
Cerulenin enhances DHA production in E. coli expressing 
M. marina pfa gene cluster
The positive effect of the antibiotic cerulenin on the 
production of DHA in marine bacteria was previously 
known. DHA-producer M. marina treated with sub-
lethal concentrations of cerulenin (0.5–2 µg/ml) showed 
a threefold increase (6–19%) in DHA production [9], 
while Colwellia psycherythraea treated with 12  µg/ml 
cerulenin showed a fourfold increase in DHA content, 
accumulating up to 10% of total FA [10]. However, lit-
tle is known about genetic modifications enhancing this 
production.
To study genetic effects on DHA production we have 
used the KEIO collection [16], a collection of single-gene 
deletions of all nonessential genes in E. coli K-12. First, 
we transferred pDHA4 to E. coli strain BW27783 (BW-
pDHA4 from here), a derivative strain from KEIO control 
strain BW25113 suitable for future assays with pBAD33 
expression system, in which arabinose transporter and 
arabinose degradative enzymes have been modified 
[17–19]. BW-pDHA4 showed an increased production in 
DHA in 72 h when compared to E. coli DH5α reported by 
Orikasa et al. [7] (from 3.7 to 7.5% DHA of total FA).
We have first determined the optimal culture time and 
temperature for DHA production using BW-pDHA4 
(Additional file 1: Fig. S1). We tested DHA production at 
different culture times obtaining 4.7% DHA/total FA at 
mid-exponential phase (24  h), 7.0% at the end of expo-
nential phase (48  h), and 4.6–5.1% during stationary 
phase (up to 96 h). In addition, we tested DHA content 
at late exponential phase in cultures at different temper-
atures (7.1% DHA/total FA at 15  °C, 3.5% at 20  °C, and 
0% at 25 °C). Therefore, we established that the best con-
ditions to produce DHA using BW-pDHA4 strain were 
48 h at 15 °C.
Afterwards, we studied the enhancement of DHA pro-
duction in the presence of different concentrations of 
Table 1 List of E. coli strains and plasmids used in this work
Relevant characteristics References
Strains
 BW25113 F‑, DE(araD‑araB)567, lacZ4787(del)::rrnB‑3, LAM‑, rph‑1, DE(rhaD‑rhaB)568, hsdR514 [16]
 BW27783 BW25113 DE(araFGH) Φ(∆araEp PCPA–araE) [19]
Plasmids
 pDHA4 pSTV29 (Takara Corp.) carrying pfaABCDE from M. marina MP‑1 (p15A OriV, ~ 10 copies, chlorampheni‑
col resistance cassette)
pfaABCD expression is controlled by native M. marina promoters, pfaE is controlled by T7 promoter
[7]
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cerulenin. As shown in Fig. 1, DHA (C22:6n3) content in 
BW-pDHA4 increased from 7.5 to 12.5, 16.1 or 17.0% in 
the presence of 0.5, 1 or 2 µg/ml cerulenin, respectively. 
Even though BW-pDHA4 achieved the highest DHA 
content at a cerulenin concentration of 2 µg/ml, we per-
formed the subsequent experiments using 1 µg/ml since 
the DHA (C22:6n3) content is almost similar at 1 or 2 µg/
ml and we had observed that high concentrations of 
cerulenin affected cell growth (Additional file 1: Fig. S2).
Cerulenin also had an effect on the overall FA compo-
sition in BW-pDHA4 (Fig.  1). Medium-chain saturated 
fatty acid content such as miristic acid (C14:0) increases 
in presence of cerulenin, while levels of palmitic acid 
(C16:0), palmitoleic acid (C16:1) and C17 cyclopropane 
acid (C17cyc) have not significant variations. In contrast, 
cis-vaccenic acid (C18:1n7) content drastically decreases. 
Similar variations in the fatty acid profile were reported 
for M. marina [9], C. psycherythraea [10] or E. coli 
expressing C. psycherythraea pfaABCDE genes [12].
DHA production is increased in ΔfabH mutant
Cerulenin was shown to inhibit FabB and FabF, two 
main KS synthases involved in conventional FA synthe-
sis [14]. Both enzymes are responsible for condensing 
malonyl-ACP with the FA growing chain. Besides FabB 
and FabF, FabH is the KS enzyme responsible of the 
initial condensation of malonyl-ACP to either acetyl-
CoA or propionyl-CoA. However, FabH is not inhibited 
by cerulenin [20]. Thus, we hypothesized that, similar to 
the inhibition of FabF and FabB by cerulenin, deletion of 
fabH could also lead to an increase of DHA production. 
To test the fabH deletion phenotype, we transformed a 
fabH knockout mutant strain from the KEIO collection 
[16] with pDHA4 (ΔfabH-pDHA4 from here). In Fig. 2a, 
we can observe a substantial improvement of DHA pro-
duction caused by fabH deletion, reaching 24% DHA rel-
ative to total FAs. This level of DHA production implies 
a threefold improvement compared to BW-pDHA4, and 
corresponds to 11.2  mg DHA/L (Table  2). Additionally, 
the absence of FabH activity altered the FA composition. 
Comparing the FA profile in Fig. 2a between BW-pDHA4 
and ΔfabH-pDHA4 strains, we observe a major decrease 
in C16:0 (36.5% BW-pDHA4 vs 16.7% ΔfabH-pDHA4), 
and C17cyc (15.4% vs 3.8%). In contrast, there is a sig-
nificant increase in long-chain FAs, such as C18:1n7 
(23.5% vs 45.2%), as well as the already mentioned 
increment in DHA. Furthermore, fabH deletion had an 
impact on cell growth (Fig. 2d and Table 2). Cells carry-
ing this deletion (ΔfabH-pDHA4) had a slower growth 
and thus a lower doubling time  (DT, Table 2) than refer-
ence strain BW-pDHA4 (5.3 h in BW-pDHA4 vs. 7.2 h in 
ΔfabH-pDHA4). 
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Fig. 1 Composition of major fatty acids in E. coli BW 27783 (pDHA4) treated with different concentrations of cerulenin (0–2 µg/ml) at 15 °C for 
72 h. Bars indicate the mean and standard deviation of the percentage of each FA in relation to total FA. Statistical analysis for each FA was made 
individually for at least three replicates using One‑Way ANOVA. Asterisks indicate the degree of significance (***p < 0.0001; **p < 0.001; *p < 0.05; ns 
not significant p > 0.05). Miristic acid—C14:0, palmitic acid—C16:0, palmitoleic acid—C16:1, C17 cyclopropane derivative—C17cyc, cis‑vaccenic 
acid—C18:1n7, DHA—C22:6n3
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In order to observe the effect of a tighter inhibition 
on the system, we analysed the effect of cerulenin on 
ΔfabH-pDHA4 cells. In this experiment, FA produc-
tion was altered simultaneously by fabH deletion and 
by FabB and FabF partial inhibition with cerulenin. 
From the data in Fig. 2b, we can see that, under these 
doubly limiting conditions, DHA production reached 
31.7% of total FAs (16.8  mg DHA/L), 4.9-fold higher 
than BW-pDHA untreated. The proportion of some 
other FA species in ΔfabH-pDHA4 treated with ceru-
lenin also changed compared to untreated BW-pDHA 
(Fig. 2c). For instance, the proportion of miristic acid 
in ΔfabH-pDHA4 treated with cerulenin (2.3%) is sig-
nificantly lower than in treated ΔfabH-pDHA4 (1.2%) 
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Fig. 2 Effect of fabH deletion and cerulenin on heterologous DHA production in E. coli strains cultured at 15 °C for 72 h. a Effect of fabH deletion 
on fatty acid composition of BW‑pDHA4 and ∆FabH‑pDHA4 in absence of cerulenin (untreated strains). b Effect of cerulenin on BW‑pDHA4 
and ∆FabH‑pDHA4 in presence of 1 μg/ml cerulenin (treated strains). c Additive effect of fabH deletion and cerulenin treatment on fatty acid 
composition. Fatty acids from ∆fabH‑pDHA4 treated with 1 μg/ml cerulenin are compared to fatty acids of untreated BW‑pDHA4. Mean and 
standard deviation of each FA in relation to total FA content is shown. Statistical analysis was made for at least three replicates using One‑Way 
ANOVA. Asterisks indicate the degree of significance (***p < 0.0001; **p < 0.001; *p < 0.05; ns not significant p > 0.05). Miristic acid—C14:0, palmitic 
acid—C16:0, palmitoleic acid—C16:1, C17 cyclopropane derivative—C17cyc, cis‑vaccenic acid—C18:1n7, DHA—C22:6n3. d Growth curve of 
BW‑pDHA4 and ∆FabH‑pDHA4 with 0 and 1 μg/ml of cerulenin. Each curve was measured for 52 h at 15 °C using 12 independent cultures
Table 2 Effect of  fabH deletion and  cerulenin inhibition 
(1 µg/ml) on DHA producing strains
a Maximum doubling time calculated during the exponential phase for each 
condition
b DHA production is represented by relative (% DHA/total FA) and absolute (mg 
DHA per liter of culture) quantification of DHA for each strain and condition
Mean and standard deviation is shown. Asterisks indicate the degree of 
significance (*** p < 0.0001; ** p < 0.001)
Strain BW—pDHA4 ΔfabH—pDHA4
Cerulenin 0 µg/ml 1 µg/ml 0 µg/ml 1 µg/ml
Doubling time (h)a 5.3 ± 0.2 6.2 ± 0.2*** 7.2 ± 0.2*** 8.8 ± 0.7***
%DHA/total  FAb 7.5% 15.5%** 23.9%*** 31.7%***
mg DHA/lb 2.8 ± 0.4 8.1 ± 0.24*** 11.2 ± 1.9*** 16.8 ± 1.6***
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while C17cyc is reduced from 15.4% in untreated BW-
pDHA4 to 4.2% in treated ΔfabH-pDHA4. In relation 
to cell growth, this double inhibited system showed a 
low growth (Fig. 2d) with a  DT of 8.8 h (Table 2).
Effect of other KO mutants on DHA production
To check the effect of other FA-synthesis mutations of 
the KEIO collection, as well as to stablish a control for the 
effect of in-frame deletions, we tested DHA production 
in a series of KEIO mutants transformed with pDHA4 
(Fig. 3). The following mutants were selected (Table 3):
i. Three non-essential genes related to FA biosynthesis 
besides fabH: fabF (ketosynthase responsible for cis-
vaccenic production), fabR (global regulator of fatty 
acid metabolism) and tesA (FA thioesterase). These 
three mutant strains, transformed with pDHA4, did 
not show a significant improvement in DHA pro-
duction compared to control strain BW-pDHA4. As 
shown in Fig.  3, DHA content increased from 7.5% 
in BW-pDHA4 to 10.9% in ΔfabR-pDHA4 and 12.5% 
in ΔtesA-pDHA4 under the same culture conditions. 
Curiously, the single deletion of fabF (ΔfabF-pDHA4) 
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Fig. 3 DHA production in KEIO mutant strains and reference strain BW27783 transformed with pDHA4 plasmid. Bars indicate the mean and 
standard deviation of DHA percentage in relation to total FA content. Statistical analysis of each FA content for each strain was performed for at least 
three replicates using One‑Way Anova. Asterisks indicate the degree of significance (***p < 0.0001; ns not significant p > 0.05)
Table 3 Selected mutants from KEIO collection [16] for improvement of DHA production by expression of pDHA4 plasmid
Gene code is taken from E. coli MG1655 strain in Ecocyc database
Gene name Gene code Protein Process
fabF b1095 Ketoacyl synthase II Fatty acid biosynthesis
fabH b1091 Ketoacyl synthase III
fabR b3963 Fatty acid synthesis repressor
tesA b0494 Acyl‑CoA thioesterase I
fadE b0221 Acyl‑CoA dehydrogenase Fatty acid degradation
fadR b1187 Global lipid metabolism regulator
glpR b3423 Glycerol‑3‑phosphate transcriptional repressor Carbon metabolism regulation
gntR b3438 Entner‑Doudoroff pathway transcriptional repressor
phoB b0399 Response factor. Phosphate dual regulation factor General cell regulation
phoP b1130 Response factor. Phosphate dual regulation factor
rpoS b2741 Sigma factor. Represses of fadA, fadB, fadE and fadH
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only increased DHA production to 9.1%, a less prom-
inent effect than the dual partial inhibition of FabB 
and FabF produced by cerulenin (17%) shown previ-
ously.
ii. Two genes coding for enzymes involved in the FA 
degradation pathway, in order to avoid DHA con-
sumption: fadE (FA β-oxidation enzyme), fadR (FA 
metabolism regulator). None of these two mutants 
showed a significant difference in the DHA content 
compared to BW-pDHA4, since ΔfadE-pDHA4 and 
ΔfadR-pDHA4 had a DHA content of 8.9 and 10.7% 
respectively.
iii. Deletion of gene regulation factors involved in car-
bon metabolism pathways: glpR (repressor of the 
glycerol-3-phosphate regulon) and gntR (repressor 
of the Entner-Doudoroff pathway). Both mutants 
did not have a significant difference in DHA content 
compared to the BW-pDHA4, from 7.5 to 9.8% in 
ΔglpR-pDHA4 and 11.0% in ΔgntR-pDHA4.
iv. Three genes coding for general regulation proteins 
involved in the FA metabolic switch between bio-
synthesis and degradation [20]: phoB and phoP (dual 
regulator involved in FA regulation network) and 
rpoS (sigma factor involved in FA regulation net-
work). The regulation mutants did not show a sig-
nificant difference in the DHA content compared to 
BW-pDHA4, since ΔphoB-pDHA4, ΔphoP-pDHA4 
and ΔrpoS-pDHA4 had a 5.0, 9.6 and 12.9% of DHA.
Discussion
The main goal in this work was to obtain an E. coli strain 
with the ability to produce higher amounts of DHA, 
avoiding the addition of exogenous expensive com-
pounds such as cerulenin to the culture. Previous stud-
ies [9–11] suggested that there is substrate competition 
between FAS and Pfa biosynthesis pathways, since 
Claisen condensation of malonyl-ACP and acetyl-CoA 
initiates both synthetic pathways. Sublethal concentra-
tions of cerulenin partially alter the KS activity of FabB 
and FabF in FAS system, which increases the concentra-
tion of the intracellular malonyl-CoA pool available for 
the heterologous DHA pathway [15]. Furthermore, it has 
been previously reported [11] that the heterologous Pfa 
system from Thraustochytrium sp. expressed in E. coli 
was not inhibited by cerulenin, while the FAS system was 
indeed affected. Thus, the Pfa pathway seems to use the 
intracellular malonyl-CoA pool for DHA production, 
which increases when conventional FA synthesis (via the 
fab pathway) is partially blocked.
In fact, our in  vivo results showed that DHA produc-
tion is certainly improved in strain ΔfabH-pDHA4 
(Fig.  2), even when cerulenin is not present in the 
medium, which could indicate that the availability of 
malonyl-CoA is actually a bottleneck for DHA pro-
duction in our system. Thus, as shown in the model we 
present in Fig. 4, our data suggests the existence of a sub-
strate competition mechanism between the FA synthase 
systems FAS and Pfa, analogous to what happens in the 
case of cerulenin inhibition.
In fatty acid synthesis, substrates bound to ACP are 
processed by three different KS. In the first cycle of 
elongation, FabH (KS III) condenses the substrates mal-
onyl-ACP and acetyl-CoA to produce acetoacetyl-ACP. 
Afterwards, FabB (KS I) plays the essential role of elon-
gating the primer acetoacetyl-ACP to 16-C long FA and 
elongate unsaturated fatty acids. Furthermore, in  vitro 
studies found that FabB and FabF are also capable of 
using acetyl-ACP as a substrate by a side reaction in 
which malonyl-ACP is decarboxylated to acetyl-ACP, and 
then used for Claisen condensation with a malonyl-ACP 
residue [21]. Although this hypothesis is based on an 
in  vitro assay, it could explain the residual FA synthetic 
activity in the strain carrying fabH deletion. Further-
more, it has been observed that a ΔfabH Lactobacillus 
lactis strain still retained 10% FA activity [22], probably 
due to side initiation KS reactions carried out by FabB 
and FabF [23].
Finally, last elongation cycle in E. coli is catalysed by 
FabF (KS II), adding two carbons to palmitoleic acid to 
produce cis-vaccenic acid [20]. This subsequent activity 
of the three ketosynthases could explain why the deletion 
of the main initial condensation enzyme of FA biosynthe-
sis seems to have an even larger impact on DHA produc-
tion than the inhibition caused by cerulenin, since FabH 
catalyses an earlier step during biosynthesis than FabB 
and FabF. Furthermore, the secondary catalytic ability of 
FabB is observed in ΔfabH strain treated with cerulenin, 
which shows a higher level of DHA, meaning the levels of 
intracellular malonyl-CoA is even higher.
Additionally, FabH has been reported as essential in 
strains lacking spoT [22]; however, in wild type strains, it 
has been proven to not be essential [16, 24]. As showed in 
Fig. 2c, the deletion of fabH has an impact on cell growth, 
same way the inhibition of cerulenin on FabB/FabF activ-
ity does.
Interestingly, deletion of fabF did not have a note-
worthy effect on DHA content. This fact could be 
explained by the subsequent activity of the ketosyn-
thase enzymes explained previously, since the cell is 
able to generate long-chain FAs by FabB activity, and 
therefore, FabF activity is not essential. In summary, 
these data indicate that, in order to increase the intra-
cellular malonyl-CoA pool, it is necessary to intercept 
the metabolic route at the initial condensation steps 
of FA synthesis, or even earlier, at acetyl-CoA carbox-
ilase (ACC) or FabD reactions. However, FabH is the 
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only non-essential gene at this stage of FA synthesis, 
making it a good starting point for malonyl-CoA intra-
cellular accumulation. Further analysis of other KEIO 
mutants shows that genes implicated in the regulation 
of FA metabolism had no significant improvement in 
DHA production. First, the transcription factors FabR, 
FadR and RpoS, as well as PhoB and PhoP, coordinate 
the biosynthesis and degradation of FA according to 
the energetic requirements of the cell [20]. It would 
be expected that elimination of the positive regula-
tors of FA biosynthesis led to a significant increase of 
DHA. Nevertheless, no improvement in DHA produc-
tion was observed. Thus, we could only speculate that 
the tight regulation of the FA metabolic pathways is 
exerted by modulation of the key enzymes of the cycle 
in order to respond to the energetic status of the cell 
[25].
Furthermore, we selected the enzyme from 
β-oxidation pathway FadE, with the aim of reduc-
ing FA degradation and, thus, avoiding DHA catabo-
lism. However, this deletion had no impact on DHA 
accumulation. This observation was shocking since 
several studies reported that deletion of fadE and other 
genes of the β-oxidation pathway do reduce FA degra-
dation, and therefore, increase FA accumulation [20].
Conclusions
The main conclusion of this work is that deletion of fabH 
in a LC-PUFA3 producer organism, which carries a Pfa 
synthase, improves DHA production by diminishing sub-
strate competition with FAS. Furthermore, this approach 
could be applied to other metabolic routes, which share 
malonyl-CoA as common precursor with FA synthesis, 
such as polyketide synthases, and other metabolites.
This approximation is a proof of concept that shows the 
potential of altering carbon fluxes towards a heterolo-
gous pathway.
Methods
Bacterial cells and cultivation
Escherichia coli BW27783 (Table  1) was transformed 
with plasmid pDHA4 [7] to be used as host for the 
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Ethanol degradaon
…
FabH
FabF
KS
FabB
Malonyl-CoA
Acetyl-CoA
KO
Fig. 4 Scheme that represents a model for metabolic utilization of acetyl‑CoA and malonyl‑CoA by FAS and Pfa pathways. In a cell carrying the 
Pfa system, there is competition for substrate, acetyl‑CoA and malonyl‑CoA between Pfa and FAS biosynthetic pathways. Malonyl‑CoA is mostly 
consumed by FAS synthase for canonical FA production. Partial inhibition of the initial step of FAS activity either by gene deletion (KO, red cross) or 
cerulenin enzymatic inhibition (block sign) increases DHA production due to lower consumption of the substrates by FAS, which accumulate in the 
cytoplasm and can be redirected to the alternative Pfa pathway. KS ketosynthesis, KR ketoreduction, DH dehydration, ER enoylreduction
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recombinant pfa genes. Bacterial cells were inoculated 
from an overnight culture at 37  °C grown to satura-
tion. Cultures at an initial OD = 0.15 were incubated 
on a rotary shaker (170  rpm) at 15  °C for 72  h in LB 
medium (Conda laboratories). When appropriate, kan-
amycin (50 µg/ml, Apollo Scientific) or chlorampheni-
col (25  µg/ml, Apollo Scientific) were added to the 
medium. In order to test the effect of cerulenin on cells, 
cultures were treated with a range of cerulenin concen-
trations (0–2  µg/ml, Cayman chemicals). Growth was 
determined by measuring the optical density at 600 nm 
(OD600) in a spectrophotometer (Nanodrop2000c, 
Nanodrop). Cells were collected by centrifugation in a 
Eppendorff 5810R centrifuge at 1700×g for 10  min at 
room temperature.
The growth curve of each strain was measured by OD 
at 600  nm in a Victor 3 system (Perkin Elmer) using 
24-well plates with a culture volume of 750 µl. Each data 
point for the curve was calculated by the average of 12 
independent cultures, and the maximum doubling time 
was calculated at early exponential phase.
Selected in frame mutants from KEIO collection [16] 
are summarized in Table 3. The strains were transformed 
with plasmid pDHA4 by electroporation, and checked 
for chloramphenicol resistance on LB agar plates (1.5% 
(wt/v) agar; Conda laboratories) Gene deletion of fabH 
was checked by PCR using primers FabHS (5′-GCT ACA 
AAA GAG CCT GAC GAGG) and FabHE (5′-CAA TCA 
CAC CAG CGC AAA CCAG), and primers for kanamy-
cin resistance insertion Rk1 (5′-AGC CGA ATA GCC TCT 
CCA CCCA) and Fk2 (5′-CAT CTC ACC TTG CTC CTG 
CCGA) as described previously [18].
Fatty acid analysis
FA composition and DHA quantitation were carried out 
by gas chromatography at Biomar Microbial Technolo-
gies (León, Spain) using pelleted cells. FAs were isolated 
from the samples following the Folch method [26]. The 
esterification with methanol was performed as described 
previously [27]. Concentrated FAMEs were analyzed on 
a gas chromatograph (model 7890A, Agilent) equipped 
with a capillary column DB-23 and flame ionization 
detection using helium as a carrier gas at 52.248 psi con-
stant pressure. Temperature was kept at 130 °C for 1 min, 
then it was increased to 215 °C at a 2.75 °C/min ratio, and 
finally it was maintained at 215  °C for 12  min. The col-
umn was then cleaned by a ballistic increase of tempera-
ture to 230 °C and kept at this temperature for 2 min. The 
sample was injected at 270 °C in a split–splitless chamber 
with a split ratio of 10:1. The compounds were detected 
in a flame ionization detector (FID) at 280 °C with the fol-
lowing gas flows: air (200 ml/min),  H2 (30 ml/min), and 
 N2 (22.5 ml/min). FAMEs were identified by comparing 
the retention time with commercial standard Supelco37 
Component FAME Mix (Sigma Aldrich). Quantitation 
of DHA was determined using commercial standards. 
Methyl tricosanoate was used as internal standard.
Statistical analysis
The statistical analysis of the gas chromatography 
results was made using IBM SPSS Statistics version 
22.0. (IBM Corporation). Comparison of group means 
against the control group was performed individually 
for each FA by the One-Way ANOVA software using 
Dunnet post hoc analysis. The significance value was 
set at 0.05.
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